Products

Influenza A virus cDNA and Antigen

Cat#

Product Name

Swiss Prot#

Size

Price (US$)

Order

PN1069

Recombinant Protein-Influenza A virus Hemagglutinin H6 (a.a.18 to 566)

Q80RX6

100 µg

1195

Order

PN1070

Recombinant Protein-Influenza A virus Neuraminidase N2 (a.a.36 to 451)

Q80RW3

100 µg

1195

Order

PN1071

Recombinant Protein-Influenza A virus Neuraminidase (a.a.51 to 449)

Q4U002

100 µg

1195

Order

PN1072

Recombinant Protein-Influenza A virus Nucleoprotein (a.a.51 to 498)

Q4U003

100 µg

1195

Order

PN1073

Recombinant Protein-Influenza A virus Hemagglutinin (a.a.25 to 568)

Q4U004

100 µg

1195

Order

PN1074

Recombinant Protein-Influenza A virus Hemagglutinin (a.a.51 to 568)

A0A248

100 µg

1195

Order

PN1075

Recombinant Protein-Influenza A virus Matrix protein 1 (a.a.21 to 252)

Q77NQ1

100 µg

1195

Order

PN1076

Recombinant Protein-Influenza A virus Matrix protein 2 (a.a.18 to 97)

Q9J456

100 µg

1195

Order

PN1077

Recombinant Protein-Influenza A virus Neuraminidase subtype 2 (a.a.31 to 469)

Q9J458

100 µg

1195

Order

PN1078

Recombinant Protein-Influenza A virus Matrix protein (a.a.21 to 252)

Q9EMB0

100 µg

1195

Order

PN1079

Recombinant Protein-Influenza A virus Nucleocapsid protein (a.a.21 to 498)

Q9EMB4

100 µg

1195

Order

PN1080

Recombinant Protein-Influenza A virus H5N1 Hemagglutinin (a.a.51 to 570)

C4P285

100 µg

1195

Order

PN1081

Recombinant Protein-Influenza A virus H5N1 Matrix protein M1 (a.a.35 to 252)

Q6R2G8

100 µg

1195

Order

PN1082

Recombinant Protein-Influenza A virus H5N1 Membrane ion channel M2 (a.a.18 to 97)

Q6R2G9

100 µg

1195

Order

PN1083

Recombinant Protein-Influenza A virus H4N5 Neuraminidase (a.a.51 to 472)

Q0KJ47

100 µg

1195

Order

PN1084

Recombinant Protein-Influenza A virus M1 protein (a.a.21 to 252)

Q5DL96

100 µg

1195

Order

PN1085

Recombinant Protein-Influenza A virus H3N8 Hemagglutinin (a.a.26 to 336)

C9W7X2

100 µg

1195

Order

PN1086

Recombinant Protein-Influenza A virus H2N9 Nonstructural protein 2 (a.a.21 to 121)

Q20P30

100 µg

1195

Order

PN1087

Recombinant Protein-Influenza A virus H12N1 Nucleocapsid protein (a.a.51 to 498)

Q2FCQ2

100 µg

1195

Order

PN1088

Recombinant Protein-Influenza A virus H2N5 Neuraminidase (a.a.51 to 473)

Q20W71

100 µg

1195

Order

PN1089

Recombinant Protein-Influenza A virus H1N1 Nonstructural protein 1 (a.a.21 to 237)

A4D6R9

100 µg

1195

Order

PN1090

Recombinant Protein-Influenza A virus H1N1 Hemagglutinin (a.a.18 to 575)

B2ZVN6

100 µg

1195

Order

PN1091

Recombinant Protein-Influenza A virus H2N9 Hemagglutinin (a.a.23 to 569)

Q6DWQ5

100 µg

1195

Order

PN1092

Recombinant Protein-Influenza A virus H1N1 Matrix protein 1 (a.a.21 to 252)

D1CP60

100 µg

1195

Order

RPN1069

 cDNA-Influenza A virus Hemagglutinin H6 (a.a.18 to 566)

Q80RX6

2 µg

2740

Order

RPN1070

 cDNA-Influenza A virus Neuraminidase N2 (a.a.36 to 451)

Q80RW3

2 µg

2075

Order

RPN1071

 cDNA-Influenza A virus Neuraminidase (a.a.51 to 449)

Q4U002

2 µg

1990

Order

RPN1072

 cDNA-Influenza A virus Nucleoprotein (a.a.51 to 498)

Q4U003

2 µg

2235

Order

RPN1073

 cDNA-Influenza A virus Hemagglutinin (a.a.25 to 568)

Q4U004

2 µg

2715

Order

RPN1074

 cDNA-Influenza A virus Hemagglutinin (a.a.51 to 568)

A0A248

2 µg

2585

Order

RPN1075

 cDNA-Influenza A virus Matrix protein 1 (a.a.21 to 252)

Q77NQ1

2 µg

1155

Order

RPN1076

 cDNA-Influenza A virus Matrix protein 2 (a.a.18 to 97)

Q9J456

2 µg

800

Order

RPN1077

 cDNA-Influenza A virus Neuraminidase subtype 2 (a.a.31 to 469)

Q9J458

2 µg

2190

Order

RPN1078

 cDNA-Influenza A virus Matrix protein (a.a.21 to 252)

Q9EMB0

2 µg

1155

Order

RPN1079

 cDNA-Influenza A virus Nucleocapsid protein (a.a.21 to 498)

Q9EMB4

2 µg

2385

Order

RPN1080

 cDNA-Influenza A virus H5N1 Hemagglutinin (a.a.51 to 570)

C4P285

2 µg

2595

Order

RPN1081

 cDNA-Influenza A virus H5N1 Matrix protein M1 (a.a.35 to 252)

Q6R2G8

2 µg

1085

Order

RPN1082

 cDNA-Influenza A virus H5N1 Membrane ion channel M2 (a.a.18 to 97)

Q6R2G9

2 µg

800

Order

RPN1083

 cDNA-Influenza A virus H4N5 Neuraminidase (a.a.51 to 472)

Q0KJ47

2 µg

2105

Order

RPN1084

 cDNA-Influenza A virus M1 protein (a.a.21 to 252)

Q5DL96

2 µg

1155

Order

RPN1085

 cDNA-Influenza A virus H3N8 Hemagglutinin (a.a.26 to 336)

C9W7X2

2 µg

1550

Order

RPN1086

 cDNA-Influenza A virus H2N9 Nonstructural protein 2 (a.a.21 to 121)

Q20P30

2 µg

800

Order

RPN1087

 cDNA-Influenza A virus H12N1 Nucleocapsid protein (a.a.51 to 498)

Q2FCQ2

2 µg

2235

Order

RPN1088

 cDNA-Influenza A virus H2N5 Neuraminidase (a.a.51 to 473)

Q20W71

2 µg

2110

Order

RPN1089

 cDNA-Influenza A virus H1N1 Nonstructural protein 1 (a.a.21 to 237)

A4D6R9

2 µg

1080

Order

RPN1090

 cDNA-Influenza A virus H1N1 Hemagglutinin (a.a.18 to 575)

B2ZVN6

2 µg

2785

Order

RPN1091

 cDNA-Influenza A virus H2N9 Hemagglutinin (a.a.23 to 569)

Q6DWQ5

2 µg

2730

Order

RPN1092

 cDNA-Influenza A virus H1N1 Matrix protein 1 (a.a.21 to 252)

D1CP60

2 µg

1155

Order

Influenza A virus cDNA and recombinant antigen

  • Codon-optimized cDNA is cloned into E. coli expression vector with 6x His-tag at N-terminus and ready-to-use for recombinant protein production.
  • Recombinant protein applications: Western Blot may be used for other applications determined by the user.
  • Protein Purity: >90%, as determined by SDS-PAGE under reducing conditions.
  • Protein Activity: N/A
  • Protein Tag:  Contains A 6x histidine tag at N-terminus.
  • Protein Formulation: Liquid
  • Source: Produced from E. coli

Influenza A virus is a subtype of the influenza virus that can cause respiratory illness in humans and animals. It is highly contagious and can lead to seasonal outbreaks (influenza pandemics). Symptoms include fever, cough, body aches, and fatigue. Vaccination and antiviral medications are available to prevent and treat Influenza A infections.

Influenza A virus antigen refers to a protein or substance present on the surface of the virus that can trigger an immune response. Antigens can be used in diagnostic tests to identify the presence of the virus and in vaccine development to stimulate immunity against the virus. Antigens from the Influenza A virus can vary, making it important to monitor and update vaccines accordingly to provide effective protection against new strains.

The Influenza A virus genome is the genetic material that makes up the virus and determines its characteristics and behavior. The genome of Influenza A virus is composed of RNA and is segmented into eight separate pieces, which can mix and match to create new strains of the virus. This genetic variability is one reason why the flu can be difficult to control, as new strains can emerge that are not recognized by the immune system or are resistant to current vaccines and antiviral drugs. The study of the Influenza A virus genome is important for understanding the biology of the virus, developing new diagnostic tests and treatments, and predicting the evolution of the virus.Here’s what you need to know about these proteins:

Hemagglutinin (HA) is a glycoprotein found on the surface of the influenza virus that is responsible for binding to host cells and initiating viral entry. H6 and H5N1 are specific subtypes of hemagglutinin.

Neuraminidase (NA) is another glycoprotein found on the surface of the virus that is involved in the release of new viral particles from infected cells. N2, H4N5, H2N5, and H2N9 are specific subtypes of neuraminidase.

Nucleoprotein (NP) and Nucleocapsid protein are both involved in viral RNA replication and packaging.

Matrix protein (M1 and M2) plays a crucial role in the assembly and release of new viral particles from infected cells.

Nonstructural proteins (NS1 and NS2) are involved in viral replication and inhibition of host immune responses.

The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.

 

Welcome to BitClone

Magnetic Beads Make Things Simple